Effects of M II stage oocytes zona pellucida birefringence on pregnancy outcome
Asian Pacific Journal of Tropical Medicine
;
(12): 578-582, 2013.
Article
Dans Anglais
| WPRIM
| ID: wpr-819999
ABSTRACT
OBJECTIVE@#To explore the effects of different M II stage oocytes zona pellucida birefringence on pregnancy outcome.@*METHODS@#A total of 46 couples with infertile which induced by single cause received in-vitro fertilization treatment were analyzed retrospectively, and randomly divided into the high zona birefringence (HZB)/HZB group, HZB/low zona birefringence (LZB) group and LZB/LZB group according to different oocytes zona pellucida birefringence. Intracytoplasmic sperm injection outcome was analyzed and compared.@*RESULTS@#The proportion of HZB oocytes, implantation rate and the pregnancy rate were decreased in three groups (HZB/HZB group>HZB/LZB group>LZB/LZB group) (P0.05). Logistic regression analysis showed that factors affect M II stage oocytes zona pellucida birefringence were age, basal FSH level and the LH level on the day of HCG injection. Age and FSH levels were negatively correlated with the single oocyte zona pellucida birefringence; While the LH level on the day of hCG injection was positively correlated with the single oocyte zona pellucida birefringence.@*CONCLUSIONS@#The primary influence factors on M II stage oocytes zona pellucida are age, basal FSH level and the LH level on the day of hCG injection. The birefringence value of zona pellucida can affect the pregnancy outcome.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Ovocytes
/
Implantation embryonnaire
/
Physiologie
/
Thérapeutique
/
Zone pellucide
/
Biréfringence
/
Protéines recombinantes
/
Hormone lutéinisante
/
Issue de la grossesse
/
Modèles logistiques
Type d'étude:
Étude observationnelle
/
Étude pronostique
/
Facteurs de risque
Limites du sujet:
Adulte
/
Femelle
/
Humains
/
Mâle
/
Grossesse
langue:
Anglais
Texte intégral:
Asian Pacific Journal of Tropical Medicine
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS